Quali-Tea with Anne

Anne MacNeil

A place to chat about all things Quality related.

  1. 2월 25일

    Bridging quality, engineering, and regulatory in medical devices with John Fraser

    In this episode, Anne MacNeil interviews John Fraser to explore the critical intersection of quality assurance, engineering, and regulatory compliance in the medical device industry. Discover insights on how quality is integrated from R&D to commercialization, the challenges of software regulation, and the evolving role of quality engineers in medtech. **Key topics:** - The role of quality in early product development and design controls - Differences between R&D and engineering in medical device development - When to implement design controls: timing and considerations - Unique challenges of software as a medical device (SaMD), including cybersecurity and rapid iteration - How regulatory frameworks like ISO 14971 inform risk assessments - Collaboration gaps between quality, regulatory, and engineering teams - The importance of building quality into organizational culture from the start - Future trends and the growing need for dedicated roles at the intersection of compliance and engineering **Timestamps:** 00:00 - Introduction to quality in medtech R&D and the importance of early integration 02:28 - Balancing compliance with innovation in product development 03:18 - Differences between R&D and engineering roles across industries 04:12 - When to start applying design controls in medical device projects 05:23 - Risks and timelines involved in iterative development, especially for IVDs and software 06:53 - Classification of high-risk versus low-risk devices and early controls 08:12 - The value of designing quality processes early and avoiding rework 09:39 - How engineers follow standards without realizing they meet regulatory requirements 11:47 - Challenges specific to software development in medical devices 13:15 - Unique considerations for cybersecurity and data privacy 15:12 - The intersection of quality management, cybersecurity, and regulatory oversight 16:23 - Responsibility sharing between quality systems and cybersecurity frameworks 18:47 - Overlapping risk assessments for safety and security risks 20:33 - How regulatory bodies evaluate security and data privacy in submissions 22:14 - Navigating the organizational landscape: roles, silos, and collaboration gaps 23:43 - Building and integrating a systems engineering approach in medtech 26:00 - Nuanced regulatory requirements for device safety versus usability and risk 28:23 - Practical risk management strategies over over-engineering solutions 28:52 - How harm is defined in ISO 14971 and its application to cybersecurity risks 29:47 - The evolving career landscape: growth areas at the intersection of compliance and engineering **Resources & Links:** - [ISO 14971 Risk Management Standard](https://www.iso.org/standard/72853.html) - [ISO 13485 Medical Devices Quality Management Systems](https://www.iso.org/standard/59752.html) - [ISO 27001 Information Security Management](https://www.iso.org/isoiec-27001-information-security.html) - [Design Controls in Medical Devices (FDA Guidance)](https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/design-controls) - [Cybersecurity in Medical Devices](https://www.fda.gov/medical-devices/cybersecurity-medical-devices) - [EU Accessibility Act](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32021L0525) --- *This episode offers valuable insights for professionals navigating compliance, engineering, and quality assurance in the evolving field of medical technology. Whether you're in software, hardware, or integrated devices, understanding how to embed quality from the ground up is key to successful product launches and regulatory approval.*

    30분
  2. 2025. 10. 13.

    Exploring the World of Psychedelics

    In this conversation, Anne MacNeil and Karina Lahnakoski explore the world of psychedelics, discussing their definitions, clinical applications, and the regulatory landscape surrounding them. They delve into the manufacturing and quality control challenges specific to psychedelics, operational considerations in production, and the differences between botanical and synthetic sources. The discussion also touches on the future of psychedelics in medicine, highlighting the growing interest and potential benefits for mental health treatment. Takeaways Psychedelics are psychoactive compounds that affect perception. Classical psychedelics include psilocybin, LSD, and DMT. MDMA and ketamine are also considered psychedelics in some contexts. Clinical trials for psychedelics have gained momentum since 2018. Regulatory frameworks are evolving to allow more access to psychedelics. Manufacturing psychedelics requires adherence to strict quality control standards. Operational considerations include high-potency product handling and security measures. Supplier qualification is essential for controlled substances. Botanical psychedelics may offer different benefits compared to synthetic ones. The future of psychedelics in medicine looks promising with ongoing research. Titles Exploring the World of Psychedelics Psychedelics: A New Frontier in Mental Health Chapters 00:00 Introduction to Psychedelics 01:57 Clinical Trials and Regulatory Landscape 05:14 Manufacturing and Quality Control of Psychedelics 09:41 Operational Considerations in Psychedelic Manufacturing 12:17 Supplier and Customer Qualification Requirements 14:06 Stability and Sourcing of Psychedelics 16:10 Future of Psychedelics in Medicine

    18분

소개

A place to chat about all things Quality related.